O'Hara SM - Search Results

1

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ. Cohen SJ, et al. Clin Colorectal Cancer. 2006 Jul;6(2):125-32. doi: 10.3816/CCC.2006.n.029. Clin Colorectal Cancer. 2006. PMID: 16945168

2

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.

O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW. O'Hara SM, et al. Clin Chem. 2004 May;50(5):826-35. doi: 10.1373/clinchem.2003.028563. Epub 2004 Feb 26. Clin Chem. 2004. PMID: 14988224

3

Global gene expression profiling of circulating tumor cells.

Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM. Smirnov DA, et al. Cancer Res. 2005 Jun 15;65(12):4993-7. doi: 10.1158/0008-5472.CAN-04-4330. Cancer Res. 2005. PMID: 15958538

4

Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.

Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW, O'Hara SM. Smirnov DA, et al. Cancer Res. 2006 Mar 15;66(6):2918-22. doi: 10.1158/0008-5472.CAN-05-4003. Cancer Res. 2006. PMID: 16540638

5

Physiological stress induces the metastasis marker AGR2 in breast cancer cells.

Zweitzig DR, Smirnov DA, Connelly MC, Terstappen LW, O'Hara SM, Moran E. Zweitzig DR, et al. Mol Cell Biochem. 2007 Dec;306(1-2):255-60. doi: 10.1007/s11010-007-9562-y. Epub 2007 Aug 11. Mol Cell Biochem. 2007. PMID: 17694278

6

Apoptosis of circulating tumor cells in prostate cancer patients.

Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'hara SM, Russell T, Terstappen LW. Larson CJ, et al. Cytometry A. 2004 Nov;62(1):46-53. doi: 10.1002/cyto.a.20073. Cytometry A. 2004. PMID: 15472900 Free article.

7

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.

Moreno JG, O'Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LW. Moreno JG, et al. Urology. 2001 Sep;58(3):386-92. doi: 10.1016/s0090-4295(01)01191-8. Urology. 2001. PMID: 11549486

8

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ. Chen BT, et al. Urology. 2005 Mar;65(3):616-21. doi: 10.1016/j.urology.2004.10.053. Urology. 2005. PMID: 15780403

9

Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.

Moreno JG, O'Hara SM, Long JP, Veltri RW, Ning X, Alexander AA, Gomella LG. Moreno JG, et al. Urology. 1997 Apr;49(4):515-20. doi: 10.1016/s0090-4295(97)00016-2. Urology. 1997. PMID: 9111619 Clinical Trial.

10

Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing.

Sodowich BI, Zweitzig DR, Riccardello NM, O'Hara SM. Sodowich BI, et al. BMC Microbiol. 2013 Aug 13;13:191. doi: 10.1186/1471-2180-13-191. BMC Microbiol. 2013. PMID: 23941533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters